Market Definition:
Injectable contraceptive is a form of birth control that is administered by injection into the body and provides long-term protection from unwanted pregnancy. It is a safe and effective method of contraception, and it works by preventing the release of eggs from the ovaries, thickening the cervical mucus to prevent sperm from entering the uterus, and thinning the lining of the uterus so that a fertilized egg cannot implant.
Injectable contraceptives are available in two types: Depo-Provera, which is a progestin-only injection, and Lunelle, which is a combination of estrogen and progestin. The injection is given every 12 weeks, and it is important to receive the injection on time in order to maintain its effectiveness. Common side effects may include irregular menstrual bleeding, weight gain, headaches, and depression.
Injectable contraceptives are a good option for women who want a long-term, highly effective form of contraception that does not require daily attention. It is also a good choice for women who cannot use other forms of contraception due to medical conditions or other reasons. However, it is important to note that injectable contraceptives do not provide protection against sexually transmitted diseases, and other forms of contraception should be used in addition to the injection to prevent STDs.
Injectable contraceptives are a safe and effective form of contraception, and they offer long-term protection from unwanted pregnancy. It is important to discuss the risks and benefits with a health care provider before deciding if injectable contraception is the right choice for you.
To Know More: https://www.globalinsightservices.com/reports/injectable-contraceptive-market/
Market Outlook:
Injectable contraceptive technology has become increasingly popular in recent years due to its convenience, effectiveness, and long-term protection against unintended pregnancy. Injectable contraceptives are administered via injection into the body and are designed to provide long-lasting protection against pregnancy. Injectable contraceptives can last up to three months, depending on the type of injection, and are considered to be a safe and reliable form of contraception.
One of the key trends in injectable contraceptive technology is the development of new and improved formulations. Injectable contraceptives are typically composed of either progestin or a combination of progestin and estrogen. Recent advances in injectable contraceptive technology have resulted in the development of new combination formulations that are more effective and have fewer side effects than traditional formulations. For example, the contraceptive injection Depo-Provera contains a combination of progestin and estrogen and has been found to be more effective and have fewer side effects than the traditional progestin-only injection.
Another key trend in injectable contraceptive technology is the development of long-acting reversible contraceptives (LARCs). LARCs are designed to provide long-term protection against unintended pregnancy and are typically administered in an injection every three months. The most popular LARCs include the contraceptive injection Depo-Provera, the contraceptive implant Implanon, and the contraceptive intrauterine device (IUD). LARCs are highly effective and have the potential to provide long-term protection against unintended pregnancy.
In addition to the development of new and improved formulations and LARCs, there has been an increasing focus on patient education and access to injectable contraceptives. Patient education is important for ensuring that patients understand the risks and benefits associated with injectable contraceptives and are able to make informed decisions about their contraceptive use. Access is also important, as many individuals may not have access to injectable contraceptives due to cost or lack of availability. Increasing access to injectable contraceptives can help to reduce the rate of unintended pregnancies and improve reproductive health outcomes.
Key Drivers
The injectable contraceptive market is driven by a number of factors, including the increasing prevalence of unplanned pregnancies, the rising prevalence of sexually transmitted diseases, the increasing demand for long-acting reversible contraception, and the growing awareness about the advantages of injectable contraceptives.
Unplanned pregnancies are a major issue, particularly in developing countries, and are a key driver of the injectable contraceptive market. According to the World Health Organization (WHO), an estimated 40-50% of pregnancies worldwide are unplanned. Unplanned pregnancies can have serious implications for both the mother and the child, such as increased risk of health problems, poverty, and social exclusion. To reduce the rate of unplanned pregnancies, the use of contraception, particularly injectable contraceptives, has become increasingly important.
The increasing prevalence of sexually transmitted diseases (STDs) is also a major driver of the injectable contraceptive market. According to the Centers for Disease Control and Prevention (CDC), there were over 2.4 million cases of STDs in the United States in 2018, a 45% increase since 2013. The use of injectable contraceptives is an effective way to prevent the spread of STDs, as they provide long-term protection.
Restraints & Challenges
The key restraints and challenges in the Injectable Contraceptive market are the lack of awareness and understanding of the product, side effects, and the cost associated with the product.
Firstly, there is a lack of awareness and understanding of injectable contraceptives among women and girls. Many women and girls are not aware of the availability and effectiveness of injectable contraceptives. This is due to a lack of information about the product, and the lack of access to healthcare facilities and services that provide information on the product. Furthermore, there are cultural and religious restrictions in many countries that prevent women and girls from accessing this form of contraception.
Secondly, there are side effects associated with the use of injectable contraceptives. These side effects may include irregular periods, headaches, breast tenderness, weight gain, and depression. These side effects may lead to discontinuation of the use of the product, as women may not be willing to endure the side effects.
Request Sample: https://www.globalinsightservices.com/request-sample/GIS25741
Research Objectives:
• Estimates and forecast the overall market size for the total market, across product, service type, type, end-user, and region
• Detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling
• Identify factors influencing market growth and challenges, opportunities, drivers and restraints
• Identify factors that could limit company participation in identified international markets to help properly calibrate market share expectations and growth rates
• Trace and evaluate key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities
• Thoroughly analyze smaller market segments strategically, focusing on their potential, individual patterns of growth, and impact on the overall market
• To thoroughly outline the competitive landscape within the market, including an assessment of business and corporate strategies, aimed at monitoring and dissecting competitive advancements.
• Identify the primary market participants, based on their business objectives, regional footprint, product offerings, and strategic initiatives
Request Customization: https://www.globalinsightservices.com/request-customization/GIS25741
Market Segments
The global Injectable Contraceptive Market is segmented by type of injectable contraceptives, application, distribution channels, and region. By type of injectable contraceptives, the market is divided into hormonal injectable contraceptives, and non-hormonal injectable contraceptives. Based on application, it is bifurcated into birth control, and family planning. On the basis of distribution channels, the market is classified into hospitals & clinics, retail pharmacies, and online pharmacies. Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The global Injectable Contraceptive Market report includes players like Bayer AG (Germany), Pfizer Inc. (United States), Merck & Co., Inc. (United States), Allergan (now part of AbbVie) (United States), Teva Pharmaceuticals (Israel), Mylan (now part of Viatris) (United States), Famy Care Ltd. (India), Jadelle (Bayer HealthCare) (Germany), Antares Pharma, Inc. (United States), and BioSante Pharmaceuticals (now ANI Pharmaceuticals) (United States).
Request Discounted Pricing: https://www.globalinsightservices.com/request-special-pricing/GIS25741
Research Scope:
• Scope – Highlights, Trends, Insights. Attractiveness, Forecast
• Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
• Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
• Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
• Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
• Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis
Buy your copy here: https://www.globalinsightservices.com/checkout/single_user/GIS25741
About Us:
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Infographic excel data pack, easy to analyze big data
• Robust and transparent research methodology
• Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.